Skip to content

    UTI AMC

    UTIAMCGood
    Financial Services·30 Apr 2025
    Management Summary

    UTI AMC delivered strong core operational growth in FY25, characterized by a 43% surge in consolidated core PAT and robust AUM expansion across mutual funds and pension segments. While overall net profit was slightly dragged down by mark-to-market (M-to-M) impacts in the international business, the company successfully turned around its equity performance and aggressively expanded its physical footprint. Management is focused on leveraging improved fund rankings to regain market share while maintaining cost discipline.

    Highlights

    8

    • Consolidated core revenue from operations for FY25 reached ₹1,445 crores, a 22% YoY increase.

    • Consolidated core profit after tax (PAT) grew 43% YoY to ₹492 crores for the full year.

    • Mutual Fund Quarterly Average AUM (QAAUM) stood at ₹3.4 lakh crore, up 16.8% YoY.

    • Declared a total dividend of ₹48 per share, including a special dividend of ₹22, representing 94% of standalone profit.

    • Equity performance improved significantly with 57% of equity AUM in the top two quartiles over a one-year period.

    • UTI Pension Fund crossed a milestone of ₹3.6 lakh crore AUM, growing 19% YoY.

    • Aggressive physical expansion with 68 new branches opened in FY25, totaling 91 in the last 15 months.

    • Digital sales contributed 47.87% of gross sales for equity and hybrid funds in Q4 FY25.

    What Changed1

    vs Q2 FY26

    Guidance items3 → 5 (+2)

    Key financials

    Single quarter

    06 metrics
    1. 01Consolidated Core Revenue₹1,445 Cr+22%YoY
    2. 02Consolidated Core PAT₹492 Cr+43%YoY
    3. 03Consolidated Net Profit₹731 Cr-5%YoY
    4. 04MF Quarterly Average AUM₹3.4 Cr+16.8%YoY
    5. 05Weighted Average Yield34 bps

    Segment breakdown

    AUMAUM Growth
    UTI Pension Fund₹3.59 Cr19%
    UTI International₹25,383 Cr—
    UTI Alternatives₹2,648 Cr34%
    Heatmap· 2 shared metrics

    Guidance & targets

    5
    CategoryTargetPriority
    Other
    Tax Rate
    23% to 24%
    		High
    Other
    Opex Inflation
    7% to 8%
    		Medium
    Margin
    Overall Yield Dilution
    1 to 2 bps
    		Medium
    Headcount
    Consolidated Employee Cost Growth
    5%
    		High
    Capex
    Capex Amount
    Lower than ₹50 crores
    		Medium

    Risks & concerns

    4
    RiskSeverity

    Yield Dilution from Product Mix

    High inflows into ETFs and Index funds (low-yield products) are expected to dilute overall weighted average yield by 1-2 bps. — Management acknowledged

    medium

    Mark-to-Market (M-to-M) Volatility

    UTI International saw a sharp drop in investment income (₹112 cr to ₹31 cr) due to M-to-M impacts on seed capital in the Innovation and Dynamic Equity funds. — Both acknowledged

    medium

    Market Volatility Impacting Retail Behavior

    Equity flows contracted 14.4% MoM in March 2025, suggesting investor caution amidst market volatility. — Management acknowledged

    low

    Areas of Evasion(1)

    • Slightly vague on the exact timeline for when international business investments will monetize into significant revenue.

    Q&A highlights

    3

    “Q4, I think overall tax rate... is because of a change in the deferred tax liability on account of the budgetary regulation change where the indexation benefit was withdrawn.”

    Explains the temporary spike in tax rate which impacted Q4 net profit, providing clarity that future rates will normalize to 23-24%.

    asked by Mohit Mangal, Centrum Broking

    2 min read5 chapters

    Detailed Narrative

    01

    Core Profitability and Dividend Payout

    UTI AMC reported a robust 43% YoY growth in consolidated core PAT for FY25, reaching ₹492 crores. This operational strength allowed the company to declare a substantial dividend of ₹48 per share, which includes a ₹22 special dividend. The total payout represents approximately 94% of the standalone profit of ₹653 crores, signaling strong cash flow generation and a commitment to shareholder returns.

    02

    Strategic Physical and Digital Expansion

    The company executed a significant expansion strategy by opening 68 new branches in FY25, primarily in Tier-2 and Tier-3 cities. This brings the total new branch count to 91 over the last 15 months, increasing the total network to 255 branches. Despite this expansion, management noted that the physical growth was achieved with 'net zero cost addition' by rationalizing existing space and reallocating personnel. On the digital front, 47.87% of gross equity and hybrid sales were mobilized through digital platforms in Q4.

    03

    Equity Performance Turnaround

    A key highlight of the call was the turnaround in equity fund performance, with 57% of equity AUM now ranking in the top two quartiles over a one-year period. Management expects this improved performance to drive market share gains over the next 18-24 months as 'gatekeepers' and distributors typically look at 3-year performance cycles. Net sales for equity and hybrid funds moved from a negative ₹4,230 crores in the previous year to a positive ₹1,178 crores in FY25.

    04

    Subsidiary Performance: Pension and International

    UTI Pension Fund reached a milestone of ₹3.6 lakh crore AUM, maintaining a 24.86% market share in the NPS industry. The subsidiary contributed ₹57 crores to consolidated PAT. UTI International, however, faced headwinds as investment income dropped from ₹112 crores to ₹31 crores due to M-to-M losses and currency impacts on seed capital investments in flagship funds like the India Dynamic Equity Fund ($805 million AUM).

    05

    Yield Outlook and Cost Management

    Management anticipates a slight dilution in the overall weighted average yield (currently 34 bps) by 1-2 bps in FY26. This is primarily attributed to the rapid growth of lower-yielding ETF and Index funds, which saw AUM grow 23% to ₹1.41 lakh crore. To counter this, the company has implemented rationalization of distributor commissions. Employee costs are projected to grow by 5% on a consolidated basis in FY26, while other Opex is expected to track inflation at 7-8%.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.